Maypro launches three ingredients for stress and sleep, mental clarity, and mood support

- Last updated on GMT

Approximately 21 million American adults suffering from some type of mood disorder
Approximately 21 million American adults suffering from some type of mood disorder
Maypro Industries’ Proprietary Branded Ingredients (PBI) division is launching three new patented ingredients targeting stress and sleep, mental clarity, and mood support.

The three ingredients are branded ETAS (enzyme-treated asparagus extract) for stress and sleep, Bluenesse (lemon balm extract) for mental clarity, and Venetron (extract of Apocynum venetum​ L.)  for mood support.

With approximately 21 million American adults suffering from some type of mood disorder, an estimated 40 million experiencing anxiety, 30 million reporting problems with sleep, and over 20 million suffering from mild cognitive impairment, the market for such products is impressive.

“Considering the scope of these health concerns among Americans, and consequently the size of these markets, I am very excited about these opportunities,”​ said Dan Lifton, President of Maypro’s PBI division. “I am grateful to our manufacturer partners for their commitment to high-quality clinical research, which positions us for success.”

The recommended daily dosage of ETAS is 200 mg/day, Bluenesse is 300 mg/day, and Venetron is 50 mg/day.

Related topics: Suppliers, Cognitive function, Botanicals

Related news

Show more

Related products

show more

The Elegance of Expeller Pressed

The Elegance of Expeller Pressed

Bunge Oils | 22-May-2019 | Technical / White Paper

Simply put: today’s consumers want food, simply. Shoppers are choosing products with fewer ingredients that are closer to the fresh foods they know. One...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars